scispace - formally typeset
J

Jon Clardy

Researcher at Harvard University

Publications -  990
Citations -  62414

Jon Clardy is an academic researcher from Harvard University. The author has contributed to research in topics: Absolute configuration & Bacteria. The author has an hindex of 116, co-authored 983 publications receiving 56617 citations. Previous affiliations of Jon Clardy include Howard Hughes Medical Institute & University of Chicago.

Papers
More filters
Journal ArticleDOI

New furanoid diterpenoidal constituents of Tinospora malabarica

TL;DR: In this paper, two new furanoid diterpenes, malabarolide B1 and menispermacide, have been isolated from the stems of Tinospora malabara.
Journal ArticleDOI

Whole-Genome Sequence of Bacillus sp. SDLI1, Isolated from the Social Bee Scaptotrigona depilis.

TL;DR: The complete genome sequence of Bacillus sp. strain SDLI1, isolated from larval gut of the stingless bee Scaptotrigona depilis, was published in this article.
Journal ArticleDOI

Draft Genome Sequences of Six Pseudoalteromonas Strains, P1-7a, P1-9, P1-13-1a, P1-16-1b, P1-25, and P1-26, Which Induce Larval Settlement and Metamorphosis in Hydractinia echinata.

TL;DR: These genomes will allow detailed studies on bacterial factors mediating interkingdom communication as well as broader understanding of the importance of a surface-associated lifestyle and morphogenic capability.
Journal ArticleDOI

First X-Ray Study on Orientation of Addition of Phosphorus Compounds to 3-O-Alkyl-5,6-dideoxy-1,2-O-isopropylidene-6-C-nitro-α-D-xylo-hexo-5-(Z)-enofuranoses

TL;DR: In this paper, the addition of phosphorus compounds to 3O-alkyl-5,6-dideoxy-1,2-O-isopropylidene-6-C-nitro-α-D-xylo-hexo-5-(Z)-enofuranoses was first investigated by X-ray crystallographic analysis of the adduct.
Journal ArticleDOI

Synthesis, biological activity, and absolute stereochemical assignment of NPS 1392: a potent and stereoselective NMDA receptor antagonist.

TL;DR: The synthesis, biological activity, and single crystal X-ray structure of NPS 1392, (R)-(-)-3,3-bis(3-fluorophenyl)-2-methylpropan-1-amine (3a), a potent, stereoselective antagonist of the NMDA receptor, are described.